MELANOPHORE-STIMULATING HORMONE-MELATONIN ANTAGONISM IN RELATION TO COLOUR CHANGE IN XENOPUS LAEVIS

1971 ◽  
Vol 49 (4) ◽  
pp. 573-580 ◽  
Author(s):  
KAY DIERST-DAVIES ◽  
F. W. LANDGREBE ◽  
G. M. MITCHELL

SUMMARY Experiments on colour change of Xenopus laevis were performed to investigate the possibility that melatonin is the physiological antagonist to melanophore-stimulating hormone (MSH). Various amounts of substandard (SS) extract of ox posterior pituitary plus melatonin were injected into the dorsal lymph sac of adult male Xenopus laevis. Normal light-adapted, completely hypophysectomized, and anterior lobectomized animals were used. Dose—response curves were obtained for different SS dosages over a wide range of melatonin concentrations. Melatonin at very low concentrations inhibited the darkening reaction to both injected SS and endogenous MSH. In all cases more melatonin was required to inhibit the effect of SS in hypophysectomized than in normal animals. The results indicate that melatonin may be a physiological MSH antagonist in Xenopus laevis and the pituitary either contains some lightening factor itself ( Hogben's 'W' substance?) or has control over another organ (pineal gland?) where a lightening factor may be present. The unusual linear-logarithmic dose—response curves are discussed.

1984 ◽  
Vol 99 (5) ◽  
pp. 1838-1847 ◽  
Author(s):  
D S Straus ◽  
D L Coppock

Variants of the mouse embryo fibroblast X melanoma hybrid clone 100A have been isolated by a procedure that selects against cells that are able to grow in medium containing low concentrations of serum plus insulin. Three variant clones derived from this selection were found to have a much higher serum requirement than the parental clone 100A cells, as evidenced by a very low rate of DNA synthesis and growth in medium containing low concentrations of serum. Two of the variants had approximately double the number of chromosomes as the parental cell line, while one had approximately the same number of chromosomes as the parental cells. One of the variants was very strongly reverted by 5-azacytidine but not by ethyl methanesulfonate, suggesting that it reverted by a nonmutational mechanism such as a stable change in DNA methylation. Analysis of the growth requirements in hormone-supplemented serum-free media of the 100A parent, the INS 471 variant, and revertants of the variant indicated that the variant had a specific deficiency in its growth response to platelet-derived growth factor (PDGF). PDGF dose-response curves obtained with the variant cells were shifted approximately an order of magnitude toward higher PDGF concentrations relative to PDGF dose-response curves obtained with the parental 100A cells. This quantitative increase in PDGF requirement of the INS 471 variant appears to explain the increased serum requirement of this variant. Equilibrium binding experiments performed with 125I-PDGF suggest that the variant does not have a decreased number of PDGF receptors.


1979 ◽  
Vol 236 (6) ◽  
pp. E616 ◽  
Author(s):  
L N Parker ◽  
W D Odell

An animal model using dexamethosone-suppressed, castrated dogs was developed to test the hypothesis that a pituitary hormone other than ACTH modulates adrenal androgen (AA) secretion. Plasma samples were obtained every 15 min during infusions of saline, synthetic alpha 1-24 corticotropin, porcine 1-39 corticotropin (ACTH), or bovine pituitary gland extract (PE) in a wide range of doses. Androstenedione (A), dehydroepiandrosterone (DHA), and cortisol (F) were quantified by radioimmunoassay. When the ratio of AA levels was related to those of F, in order to correct for ACTH content in the PE, the slopes of the dose-response curves for corticotropin and PE were different at the 0.01 level. For A the dose-response slope for the PE was 0.18 +/- 0.5 SE, whereas that of ACTH was 0.02 +/- 0.01. For the DHA response the slopes were 0.17 +/- 0.04 for the PE and 0.04 +/- 0.03 for ACTH. Related studies showed no increase in AA levels in response to luteinizing hormone-releasing hormone, bovine growth hormone (GH), bovine prolactin, ovine thyroid-stimulating hormone (TSH), or synthetic aqueous arginine vasopressin (AVP). We conclude that a pituitary factor other than ACTH, prolactin, GH, luteinizing hormone, follicle-stimulating hormone, TSH, or AVP may be responsible for the observed increase in AA concentrations.


1985 ◽  
Vol 59 (5) ◽  
pp. 1355-1363 ◽  
Author(s):  
S. Shore ◽  
J. G. Martin

Three consecutive dose-response curves to inhaled aerosolized histamine, separated by 1-h intervals, were obtained in 20 anesthetized mongrel dogs. In general, successive histamine dose-response curves shifted progressively rightward. Changes in pulmonary resistance (RL) and dynamic compliance (Cdyn) in response to low concentrations of histamine were reproducible, but responses to high concentrations (sufficient to at least double RL or decrease Cdyn by at least 30%) decreased on successive dose-response curves. The concentration of histamine required to double RL increased significantly (P less than 0.05) from 1.01 mg/ml on the first to 1.62 and 2.02 mg/ml on the second and third dose-response curves. In contrast, consecutive methacholine dose-response curves were not significantly different. Indomethacin pretreatment (5 mg/kg iv) prevented histamine tachyphylaxis, whereas atropine (4 mg iv) did not. However, indomethacin did not alter base-line pulmonary mechanics or histamine responsiveness as measured on the first dose-response curve. We conclude that tachyphylaxis to inhaled aerosolized histamine occurs in anesthetized dogs. Our results are consistent with an important role for endogenous prostaglandins in modulating the airway responses to repeated histamine exposures.


Dose-Response ◽  
2021 ◽  
Vol 19 (4) ◽  
pp. 155932582110627
Author(s):  
Linqian Yang ◽  
Jiaying Wang ◽  
Robert A. Cheke ◽  
Sanyi Tang

Purpose Dose-response curves, which fit a multitude of experimental data derived from toxicology, are widely used in physics, chemistry, biology, and other fields. Although there are many dose-response models for fitting dose-response curves, the application of these models is limited by many restrictions and lacks universality, so there is a need for a novel, universal dynamical model that can improve fits to various types of dose-response curves. Methods We expand the hormetic Ricker model, taking the delay inherent in the dose-response into account, and develop a novel and dynamic delayed Ricker difference model (DRDM) to fit various types of dose-response curves. Furthermore, we compare the DRDM with other dose-response models to confirm that it can mimic different types of dose-response curves. Data analysis By fitting various types of dose-response data sets derived from drug applications, disease treatment, pest control, and plant management, and comparing the imitative effect of the DRDM with other models, we find that the DRDM fits monotonic dose-response data well and, in most circumstances, the DRDM has a better imitative effect to non-monotonic dose-response data with hormesis than other models do. Results The MSE of fits of the DRDM to S-shaped dose-response data (DS2-G) is not lower than those for four other models, but the MSE of fits to U-shaped (DS7) and inverted U-shaped dose-response data (DS10) were lower than for two other models. This means that the imitative effect of the DRDM is comparable to other models of monotonic dose-response data, but is a significant improvement compared to traditional models of non-monotonic dose-response data with hormesis. Conclusion We propose a novel dynamic model (DRDM) for fitting to various types of dose-response curves, which can reflect the dynamic trend of the population growth compared with traditional static dose-response models. By analyzing data, we have confirmed that the DRDM provides an ideal description of various dose-response observations and it can be used to fit a wide range of dose-response data sets, especially for hormetic data sets. Therefore, we conclude that the DRDM has a good universality for dose-response curve fitting.


1974 ◽  
Vol 32 (02/03) ◽  
pp. 356-365 ◽  
Author(s):  
F Haverkate ◽  
D. W Traas

SummaryIn the fibrin plate assay different types of relationships between the dose of applied proteolytic enzyme and the response have been previously reported. This study was undertaken to determine whether a generally valid relationship might exist.Trypsin, chymotrypsin, papain, the plasminogen activator urokinase and all of the microbial proteases investigated, including brinase gave a linear relationship between the logarithm of the enzyme concentration and the diameter of the circular lysed zone. A similar linearity of dose-response curves has frequently been found by investigators who used enzyme plate assays with substrates different from fibrin incorporated in an agar gel. Consequently, it seems that this linearity of dose-response curves is generally valid for the fibrin plate assay as well as for other enzyme plate bioassays.Both human plasmin and porcine tissue activator of plasminogen showed deviations from linearity of semi-logarithmic dose-response curves in the fibrin plate assay.


1962 ◽  
Vol 41 (1) ◽  
pp. 143-153 ◽  
Author(s):  
U. Henriques

ABSTRACT A bioassay of thyroid hormone has been developed using Xenopus larvae made hypothyroid by the administration of thiourea. Only tadpoles of uniform developmental rate were used. Thiourea was given just before the metamorphotic climax in concentrations that produced neoteni in an early metamorphotic stage. During maintained thiourea neotoni, 1-thyroxine and 1-triiodothyronine were added as sodium salts to the water for three days and at the end of one week the stage of metamorphosis produced was determined. In this way identical dose-response curves were obtained for the two compounds. No qualitative differences between their effects were noted except that triiodothyronine seemed more toxic than thyroxine in equivalent doses. Triiodothyronine was found to be 7–12 times as active as thyroxine.


2005 ◽  
Vol 8 (4) ◽  
pp. E269-E274 ◽  
Author(s):  
Sydney L. Gaynor ◽  
Gregory D. Byrd ◽  
Michael D. Diodato ◽  
Yosuke Ishii ◽  
Anson M. Lee ◽  
...  

2001 ◽  
Author(s):  
Quinton J. Nottingham ◽  
Jeffrey B. Birch ◽  
Barry A. Bodt

2021 ◽  
Vol 3 (1) ◽  
pp. 181-188
Author(s):  
Peter Bracke ◽  
Eowyn Van de Putte ◽  
Wouter R. Ryckaert

Dose-response curves for circadian phase shift and melatonin suppression in relation to white or monochromatic nighttime illumination can be scaled to melanopic weighed illumination for normally constricted pupils, which makes them easier to interpret and compare. This is helpful for a practical applications.


Sign in / Sign up

Export Citation Format

Share Document